Omnia SanaPlant Comparison
Lions mane vs Rhodiola Rosea
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Lions mane and Rhodiola Rosea: they share 7 indicated uses (arthritis / joint pain, cognitive function, cold & flu, …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Lions mane | Rhodiola Rosea | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 5/10 | 6/10 | Comparable evidence |
| Cognitive function | 7/10 | 9/10 | Stronger for Rhodiola Rosea |
| Cold & flu | 5/10 | 6/10 | Comparable evidence |
| Immune support | 5/10 | 6/10 | Comparable evidence |
| Inflammation (general) | 5/10 | 9/10 | Stronger for Rhodiola Rosea |
| Memory | 7/10 | 6/10 | Comparable evidence |
| Skin irritation | 5/10 | 6/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Diterpenoid erinacines (concentrated in the mycelium) and aromatic hericenones (in the fruiting body) are the signature low-molecular-weight compounds that stimulate nerve growth factor synthesis and underlie the mushroom's neurotrophic and neuroprotective effects.
Characteristic phenylpropanoid glycosides largely unique to Rhodiola rosea, used as a standardisation marker for commercial extracts.
Phenylethanoid glycosides considered key adaptogenic and antioxidant constituents.
Contribute to the anti-inflammatory and antioxidant activity of the root.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from anticancer action
inferred from neuroprotective action
inferred from immunomodulator action
inferred from digestive action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from neuroprotective action
inferred from immunomodulator action
inferred from ergogenic action
inferred from anti-inflammatory action
inferred from ergogenic action
Safety, Cautions & Contraindications
Mild gastrointestinal upset (nausea, bloating, diarrhoea) is the most common side effect. Rare allergic reactions can occur, particularly in individuals sensitive to mushrooms, and it may slightly lower blood sugar or have mild blood-thinning effects, so caution is advised for people on diabetes or anticoagulant medications.
Generally well tolerated. May cause agitation, insomnia, or vivid dreams in sensitive individuals — take in the morning. Avoid in manic episodes or severe anxiety. Theoretical interactions with MAOIs, SSRIs, and CNS stimulants. Avoid during pregnancy and breastfeeding.
External Ids
Botanical Description
Wood-decay fungus (not a true plant) forming a distinctive rounded, cushion-like fruiting body covered in long, dangling, tooth-like spines rather than gills or pores, resembling a white or cream 'lion's mane' or icicle cluster. It grows as a single mass rather than a typical cap-and-stem mushroom, on wounds or dead wood of hardwood trees.
Succulent perennial herb (Crassulaceae), 15-40 cm tall, with a thick, fleshy, branching rhizome that has a rose-like fragrance when cut - the origin of the name 'rosea'. Leaves are fleshy, greyish-green, oval to oblong. Small yellow (occasionally reddish) flowers are clustered in dense terminal heads; the species is dioecious, with separate male and female plants. Fruit follicles turn red as they ripen.[3]
Habitat
Grows on wounds, dead or dying wood of hardwood trees (notably oak and beech) in temperate forests of the Northern Hemisphere; also widely cultivated commercially on hardwood logs or sawdust substrate.
Native to arctic and mountainous regions of Europe, Asia and North America (circumpolar), growing in cold, rocky, high-altitude or high-latitude terrain - cliffs, rocky slopes and tundra - tolerating harsh, exposed conditions.[3]
Harvesting
Wild fruiting bodies are collected once mature; cultivated material is harvested from logs or substrate at maturity, then used fresh, dried, or processed into mycelium-based supplements.
Rhizome and root are dug from plants at least a few years old (traditionally 4-5 years), typically in autumn, then cleaned and dried. Wild populations grow slowly, so cultivated sources are increasingly preferred for sustainability.[3]
Traditional Uses
Lion's mane has a long East Asian culinary and medicinal tradition, valued in Chinese and Japanese medicine as a digestive tonic and, more recently, intensively studied for its unique ability to stimulate nerve growth factor, giving it a modern reputation as a neurotrophic and cognitive-support mushroom.[1]
Rhodiola has a long tradition of use across Scandinavian, Russian and Central Asian folk medicine as a tonic for cold-climate hardiness, physical endurance and mental stamina. It is classified as a modern 'adaptogen', and clinical trials support benefits for stress-related fatigue, mood and cognitive performance.[1, 3]
Preparations
Fruiting-body or mycelium extract standardised to erinacine or hericenone content, taken as capsules or powder; the form used in most clinical cognitive-support studies.
Dosage
A 49-week double-blind randomised trial in mild Alzheimer's disease used three erinacine A-enriched H. erinaceus mycelia capsules per day at 350 mg per capsule, i.e. 1050 mg daily. Other clinical studies of cognitive support commonly use around 1-3 g of dried fruiting body extract daily. Educational reference only, not a prescription.
References
Lookalikes Review
Drug Class Interactions
Not documented
Pairings
Not documented
Rhodiola and eleuthero (Siberian ginseng) are classic adaptogens combined in traditional and studied fixed formulas to build resistance to stress and fatigue; used together their stress-protective effects are complementary.[17, 18]
Rhodiola and schisandra are adaptogens co-formulated in clinically studied combinations for stress, fatigue and mental performance; combined use is intended to be synergistic rather than harmful.[17, 18]
References & Sources
- Szucko-Kociuba, I., Trzeciak-Ryczek, A., Kupnicka, P. and Chlubek, D (2023) 'Neurotrophic and Neuroprotective Effects of Hericium erinaceus', International Journal of Molecular Sciences, 24(21). doi:10.3390/ijms242115960 Preclinical
https://doi.org/10.3390/ijms242115960 - Contato, A.G. and Conte-Junior, C.A (2025) 'Lion's Mane Mushroom (Hericium erinaceus): A Neuroprotective Fungus with Antioxidant, Anti-Inflammatory, and Antimicrobial Potential - A Narrative Review', Nutrients, 17(8), pp. 1307. doi:10.3390/nu17081307 Meta-analysis / review
https://doi.org/10.3390/nu17081307 - Li, I.C. and Chang, H.H. and Lin, C.H. and Chen, W.P. and Lu, T.H. and Lee, L.Y. and Chen, Y.W. and Chen, Y.P. and Chen, C.C. and Lin, D.P (2020) 'Prevention of Early Alzheimer's Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study', Frontiers in Aging Neuroscience, 12, pp. 155. doi:10.3389/fnagi.2020.00155 Clinical study
https://doi.org/10.3389/fnagi.2020.00155 - Friedman, M (2015) 'Chemistry, Nutrition, and Health-Promoting Properties of Hericium erinaceus (Lion's Mane) Mushroom Fruiting Bodies and Mycelia and Their Bioactive Compounds', Journal of Agricultural and Food Chemistry, 63(32), pp. 7108-7123. doi:10.1021/acs.jafc.5b02914 Meta-analysis / review
https://doi.org/10.1021/acs.jafc.5b02914 - Xie, G. and Tang, L. and Xie, Y. and Xie, L (2022) 'Secondary Metabolites from Hericium erinaceus and Their Anti-Inflammatory Activities', Molecules, 27(7), pp. 2157. doi:10.3390/molecules27072157 Preclinical
https://doi.org/10.3390/molecules27072157 - Li, H., Feng, J., Liu, C., Hou, S., Meng, J., Liu, J.Y. and others (2024) 'Polysaccharides from an edible mushroom, Hericium erinaceus, alleviate ulcerative colitis in mice by inhibiting the NLRP3 inflammasomes and reestablish intestinal homeostasis', International Journal of Biological Macromolecules. doi:10.1016/j.ijbiomac.2024.131251 Preclinical
https://doi.org/10.1016/j.ijbiomac.2024.131251 - Shi, X.Z., Zhang, X.Y., Wang, Y.Y., Zhao, Y.M. and Wang, J (2024) 'Polysaccharides from Hericium erinaceus and its immunomodulatory effects on RAW 264.7 macrophages', International Journal of Biological Macromolecules. doi:10.1016/j.ijbiomac.2024.134947 Preclinical
https://doi.org/10.1016/j.ijbiomac.2024.134947 - Liu, J.H., Li, L., Shang, X.D., Zhang, J.L. and Tan, Q (2016) 'An experimental research on the anti-gastric-cancer activity of hericenone B extracted from Hericium erinaceus', 37(1), pp. 1--8. Traditional / reference
https://scholar.google.com/scholar?q=An%20experimental%20research%20on%20the%20anti-gastric-cancer%20activity%20of%20hericenone%20B%20extracted%20from%20Hericium%20erinaceus - Mori, K., Inatomi, S., Ouchi, K., Azumi, Y. and Tuchida, T (2009) 'Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial', 23(3), pp. 367--372. doi:10.1002/ptr.2634 Randomized trial
https://doi.org/10.1002/ptr.2634 - National Institutes of Health (2023) 'Hericium erinaceus'. Available at: https://pubmed.ncbi.nlm.nih.gov/?term=hericium+erinaceus Traditional / reference
https://pubmed.ncbi.nlm.nih.gov/?term=hericium+erinaceus - Pellegrino, R. and Gravina, A.G (2025) 'Potential of traditional Chinese medicine in gastrointestinal disorders: Hericium erinaceus in chronic atrophic gastritis', World Journal of Gastroenterology, 31(20). doi:10.3748/wjg.v31.i20.106615 Traditional / reference
https://doi.org/10.3748/wjg.v31.i20.106615 - Docherty, S., Doughty, F.L. and Smith, E.F (2023) 'The Acute and Chronic Effects of Lion's Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study', Nutrients, 15(22). doi:10.3390/nu15224842 Randomized trial
https://doi.org/10.3390/nu15224842 - Surendran, G., Saye, J., Binti Mohd Jalil, S., Spreadborough, J., Duong, K., Shatwan, I.M. and others (2025) 'Acute effects of a standardised extract of Hericium erinaceus (Lion's Mane mushroom) on cognition and mood in healthy younger adults: a double-blind randomised placebo-controlled study', Frontiers in Nutrition. doi:10.3389/fnut.2025.1405796 Randomized trial
https://doi.org/10.3389/fnut.2025.1405796 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
- Ivanova Stojcheva, E. and Quintela, J.C (2022) 'The Effectiveness of Rhodiola rosea L. Preparations in Alleviating Various Aspects of Life-Stress Symptoms and Stress-Induced Conditions - Encouraging Clinical Evidence', Molecules, 27(12), pp. 3902. doi:10.3390/molecules27123902 Meta-analysis / review
https://doi.org/10.3390/molecules27123902 - Pu, W.L., Zhang, M.Y., Bai, R.Y., Sun, L.K. and others (2019) 'Anti-inflammatory effects of Rhodiola rosea L.: A review', Biomedicine & Pharmacotherapy, 121, pp. 109552. doi:10.1016/j.biopha.2019.109552 Meta-analysis / review
https://doi.org/10.1016/j.biopha.2019.109552 - Panossian, A., Wikman, G. and Sarris, J (2010) 'Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy', Phytomedicine, 17(7), pp. 481-493. doi:10.1016/j.phymed.2010.02.002 Meta-analysis / review
https://doi.org/10.1016/j.phymed.2010.02.002 - Tinsley, G.M., Jagim, A.R., Potter, G.D.M., Garner, D. and Galpin, A.J (2023) 'Rhodiola rosea as an adaptogen to enhance exercise performance: a review of the literature', The British Journal of Nutrition, 131(3), pp. 461-473. doi:10.1017/S0007114523001988 Meta-analysis / review
https://doi.org/10.1017/S0007114523001988 - Cropley, M., Banks, A.P. and Boyle, J (2015) 'The Effects of Rhodiola rosea L. Extract on Anxiety, Stress, Cognition and Other Mood Symptoms', Phytotherapy Research, 29(12), pp. 1934-1939. doi:10.1002/ptr.5486 Randomized trial
https://doi.org/10.1002/ptr.5486 - Amsterdam, J.D. and Panossian, A.G (2016) 'Rhodiola rosea L. as a putative botanical antidepressant', Phytomedicine, 23(7), pp. 770-783. doi:10.1016/j.phymed.2016.02.009 Meta-analysis / review
https://doi.org/10.1016/j.phymed.2016.02.009 - Olsson, E.M., von Scheele, B. and Panossian, A.G (2009) 'A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue', Planta Medica, 75(2), pp. 105-112. doi:10.1055/s-0028-1088346 Randomized trial
https://doi.org/10.1055/s-0028-1088346 - Ishaque, S., Shamseer, L., Bukutu, C. and Vohra, S (2012) 'Rhodiola rosea for physical and mental fatigue: a systematic review', BMC Complementary and Alternative Medicine, 12, pp. 70. doi:10.1186/1472-6882-12-70 Meta-analysis / review
https://doi.org/10.1186/1472-6882-12-70 - Borgonetti, V., Governa, P., Biagi, M., Dalia, P. and Corsi, L (2019) 'Rhodiola rosea L. modulates inflammatory processes in a CRH-activated BV2 cell model', Phytomedicine, 68, pp. 153143. doi:10.1016/j.phymed.2019.153143 Preclinical
https://doi.org/10.1016/j.phymed.2019.153143 - Coors, A., Brosch, M., Kahl, E., Khalil, R. and others (2019) 'Rhodiola rosea root extract has antipsychotic-like effects in rodent models of sensorimotor gating', Journal of Ethnopharmacology, 235, pp. 320-328. doi:10.1016/j.jep.2019.02.031 Preclinical
https://doi.org/10.1016/j.jep.2019.02.031 - Darbinyan, V. et al (2000) 'Rhodiola rosea in stress induced fatigue — a double blind cross-over study of a standardized extract SHR-5', 7(5), pp. 365--371. Randomized trial
https://scholar.google.com/scholar?q=Rhodiola%20rosea%20in%20stress%20induced%20fatigue%20%E2%80%94%20a%20double%20blind%20cross-over%20study%20of%20a%20standardized%20extract%20SHR-5 - Kelly, G.S (2001) 'Rhodiola rosea: a possible plant adaptogen', 6(3), pp. 293--302. Traditional / reference
https://scholar.google.com/scholar?q=Rhodiola%20rosea%3A%20a%20possible%20plant%20adaptogen - Panossian, A., Wikman, G. and Sarris, J (2010) 'Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy', 17(7), pp. 481--493. doi:10.1016/j.phymed.2010.02.002 Randomized trial
https://doi.org/10.1016/j.phymed.2010.02.002 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Maniscalco, I., Toffol, E., Giupponi, G. and Conca, A (2014) 'The interaction of Rhodiola rosea and antidepressants. A case report', Neuropsychiatrie, 29(1), pp. 36-38. doi:10.1007/s40211-014-0124-8 Clinical study
https://doi.org/10.1007/s40211-014-0124-8 - van Diermen, D., Marston, A., Bravo, J., Reist, M., Carrupt, P.A. and Hostettmann, K (2009) 'Monoamine oxidase inhibition by Rhodiola rosea L. roots', Journal of Ethnopharmacology, 122(2), pp. 397-401. doi:10.1016/j.jep.2009.01.007 Preclinical
https://doi.org/10.1016/j.jep.2009.01.007 - Panossian, A.G (2013) 'Adaptogens in mental and behavioral disorders', Psychiatric Clinics of North America, 36(1), pp. 49-64. doi:10.1016/j.psc.2012.12.005 Meta-analysis / review
https://doi.org/10.1016/j.psc.2012.12.005 - Karosanidze, I., Kiladze, U., Kirtadze, N., Giorgadze, M. and Panossian, A (2022) 'Efficacy of Adaptogens in Patients with Long COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial', Pharmaceuticals, 15(3), pp. 345. doi:10.3390/ph15030345 Randomized trial
https://doi.org/10.3390/ph15030345
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.